Kiniksa Pharmaceuticals, Ltd. (KNSA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:44PM EDT. Market open.
| Previous close | 19.38 |
| Open | 20.13 |
| Bid | 19.97 x 100 |
| Ask | 20.00 x 100 |
| Day's range | 19.63 - 20.40 |
| 52-week range | 12.94 - 22.09 |
| Volume | |
| Avg. volume | 387,666 |
| Market cap | 1.417B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 153.62 |
| EPS (TTM) | 0.13 |
| Earnings date | 23 July 2024 - 29 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 30.00 |
Simply Wall St.Analyst Estimates: Here's What Brokers Think Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) After Its First-Quarter Report
It's been a good week for Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) shareholders, because the company has just...
Simply Wall St.Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) First Quarter 2024 Results Key Financial Results Revenue: US$79.9m (up 65% from...
Insider MonkeyKiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
© 2024 Yahoo. All rights reserved.